The Drosophila melanogaster CHD1 chromatin remodeling factor modulates global chromosome structure and counteracts HP1a and H3K9me2.

PLoS One

W.M. Keck Science Department, Claremont McKenna College, Pitzer College, Scripps College, Claremont, California, United States of America.

Published: September 2013

CHD1 is a conserved chromatin remodeling factor that localizes to active genes and functions in nucleosome assembly and positioning as well as histone turnover. Mouse CHD1 is required for the maintenance of stem cell pluripotency while human CHD1 may function as a tumor suppressor. To investigate the action of CHD1 on higher order chromatin structure in differentiated cells, we examined the consequences of loss of CHD1 and over-expression of CHD1 on polytene chromosomes from salivary glands of third instar Drosophila melanogaster larvae. We observed that chromosome structure is sensitive to the amount of this remodeler. Loss of CHD1 resulted in alterations of chromosome structure and an increase in the heterochromatin protein HP1a, while over-expression of CHD1 disrupted higher order chromatin structure and caused a decrease in levels of HP1a. Over-expression of an ATPase inactive form of CHD1 did not result in severe chromosomal defects, suggesting that the ATPase activity is required for this in vivo phenotype. Interestingly, changes in CHD1 protein levels did not correlate with changes in the levels of the euchromatin mark H3K4me3 or elongating RNA Polymerase II. Thus, while CHD1 is localized to transcriptionally active regions of the genome, it can function to alter the levels of HP1a, perhaps through changes in methylation of H3K9.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606111PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0059496PLOS

Publication Analysis

Top Keywords

chd1
12
chromosome structure
12
drosophila melanogaster
8
chromatin remodeling
8
remodeling factor
8
higher order
8
order chromatin
8
chromatin structure
8
loss chd1
8
over-expression chd1
8

Similar Publications

The nucleosome remodeler Chd1 is required for the re-establishment of nucleosome positioning in the wake of transcription elongation by RNA Polymerase II. Previously, we found that Chd1 occupancy on gene bodies depends on the Rtf1 subunit of the Paf1 complex in yeast. Here, we identify an N-terminal region of Rtf1 and the CHCT domain of Chd1 as sufficient for their interaction and demonstrate that this interaction is direct.

View Article and Find Full Text PDF

Hypoxia is a common feature of various solid tumors, which reduces the sensitivity of tumor cells to both radiotherapy and chemotherapy. However, hypoxia also presents an opportunity for tumor-selective therapy. The prodrug strategy, leveraging the hypoxic nature of the tumor microenvironment, shows significant potential for clinical application.

View Article and Find Full Text PDF

Discovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer.

J Med Chem

November 2024

Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

CHD1 is a chromodomain-helicase DNA-binding protein that preferentially recognizes di- and trimethylated lysine 4 on histone H3 (H3K4me2/3). Genetic studies have established CHD1 as a synthetic lethal target in phosphatase and tensin homologue (PTEN)-deficient cancers. Despite this attractive therapeutic link, no inhibitors or antagonists of CHD1 have been reported to date.

View Article and Find Full Text PDF

Identification and functional characteristics of CHD1L gene variants implicated in human Müllerian duct anomalies.

Biol Res

September 2024

Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 17 QiHeLou Street, Dongcheng District, Beijing, 100006, China.

Article Synopsis
  • Müllerian duct anomalies (MDAs) are congenital reproductive tract disorders in females, with recent advancements in whole-exome sequencing (WES) providing new insights into their genetic causes, though many mechanisms remain unclear.
  • In a study involving 97 MDAs patients, researchers identified two novel heterozygous CHD1L variants linked to these anomalies, with variants' pathogenicity confirmed through functional assays and molecular simulations.
  • The study found that the identified variants impaired CHD1L function, affecting protein localization and interactions, leading to a calculated contribution of CHD1L variants to MDAs at 4.12%.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!